Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Change In Receivables : ¥0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Change In Receivables?

Zhejiang Shapuaisi Pharmaceutical Co's change in receivables for the quarter that ended in Sep. 2024 was ¥0.0 Mil. It means Zhejiang Shapuaisi Pharmaceutical Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Zhejiang Shapuaisi Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-12.0 Mil. It means Zhejiang Shapuaisi Pharmaceutical Co's Accounts Receivable increased by ¥12.0 Mil from Dec. 2022 to Dec. 2023 .

Zhejiang Shapuaisi Pharmaceutical Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ¥38.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zhejiang Shapuaisi Pharmaceutical Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 28.34.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zhejiang Shapuaisi Pharmaceutical Co's liquidation value for the three months ended in Sep. 2024 was ¥-162.1 Mil.

Zhejiang Shapuaisi Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Change In Receivables Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

72.09

22.29

-4.19

6.83

-12.04

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Zhejiang Shapuaisi Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zhejiang Shapuaisi Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	38.065	/	122.55	*	91
=	28.34

2. In Ben Graham's calculation of liquidation value, Zhejiang Shapuaisi Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Zhejiang Shapuaisi Pharmaceutical Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	198.96	-	431.28	+	0.75 * 38.065	+	0.5 * 83.417
=	-162.1

Zhejiang Shapuaisi Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200

Website

http://www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicine, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.

Executives

Huang Ming Xiong	Directors, senior managers
Wu Jian Guo	Director
Xu Hong Sheng	senior management
Hu Zheng Guo	Director
Ge Sheng Fang	Director
Feng Xiao	Supervisors
Chen De Kang	Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines